Bronchial carcinoma: Epidemiology, diagnosis and therapy;Bronchialkarzinom: Epidemiologie, diagnostik und therapie

Internist

Volumn 44, Issue SUPPL.1, 2003, Pages

  Macha, H N ^a,b  

^a LUNGENKLINIK HEMER   (Germany)

^b Pneumologische Abteilung   (Germany)

Author keywords

Bronchial carcinoma; Chemotherapy; Epidemiology; Multimodal therapy; Radiation therapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ASIA; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CIGARETTE SMOKING; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; EPIDEMIC; EPIDEMIOLOGICAL DATA; EUROPE; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; PALLIATIVE THERAPY; PROGNOSIS; REVIEW; SURVIVAL RATE; TIME;

BIOPSY; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; DISEASE-FREE SURVIVAL; EARLY DIAGNOSIS; GERMANY; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM STAGING; SMOKING;

EID: 0037931605     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-0931-7     Document Type: Review

References (30)

1. Nackaerts, K O Axelson, E Branibilla et al. (2002) Epidemiology of lung cancer: a general update. Eur Resp Rev 84: 112-121
2. Spiro S, Porter JC (2002) Lung cancer - Where are we today. Am J Respir Crit Care Med 166: 1166-1196
3. Jaakala MS (2000) Environment tobacco smoke and respiratory disease. Eur Respir Mon 1S: 322-383
4. Jäckel KH (2000) Gesundheitsrisiken durch Passivrauchen. Dtsch Ärztebl 43: B2417-B2422
5. Hammond EC, Selikoff J, Seidmann H (1979) Asbestos exposure, cigarette smoking and death rates. Am NY Acad Sci 330: 473-490
6. Fontana RS, Sanderson DR, Taylor WF et al. (1984) Early lung cancer detection: results of the initial (prevalence). Radiologic and cytologic screenings in the Mayo Clinic Study. Am Rev Resp Dis 130: 561-565
7. Kubik A, Parkin DM, Klat M et al. (1990) Lack of benefit from semi-annual screening for cancer of the lung: follow up report of a randomized controlled trial of population of high risk males in Czechoslowakia. Int J Cancer 45: 26-33
8. Frost JK, Ball WC, Levin ML et al. (1984) Early lung cancer detection: results of the initial prevalance. Radiologic and cytologic screening in the John Hopkins Study. Am Rev Resp Dis 130: 549-554
9. Melamed, M R, Flehinger BY, Zaman MB et al. (1984) Screening for early lung cancer: Results of the Memorial Sloan-Kettering Study in New York. Chest 86: 44-53
10. Flehinger, BJ et al. (1991) The Mayo Lung Project revisited. Cancer 72: 1573-1580
11. Kaneko M, Eguki K, Okmatzu M et al. (1996) Peripheral lung cancer: screening and detection with low dose spiral CT versus radiography. Radiology 201: 718-802
12. Sone S, Takashima S, Li F et al. (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351: 1242-1245
13. Henschke CI, McCauley DI, Yankelevitz D et al. (1999) Early lung cancer action project: overall design and findings from baseline screening. Lancet 354: 99-105
14. Swensen SJ, Jett J, Sloan J et al. (2002) Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 165: 508-513
15. Diederich S, Wormanns D, Lenzen H et al. (2000) Screening for early lung cancer with low dose computed tomography of the chest. Results of baseline examinations in 919 asymptomatic smokers. Eur J Radiol 10: S 253
16. Marshall D, Simpson KN, Early CC et al. (2001) Economic decision analysis model of screening for lung cancer. Eur J Cancer 37: 1759-1767
17. Quiao YL, Tockmann LS, Li L et al. (1997) A case cohort in a screening cohort of Yuman tin miners in China. Cancer Epidemiol Biomarkers Prev 6: 893-900
18. Tockmann LS, Mushine JL, Piantadosi S et al. (1997) Prospective detection of preclinical lung cancer: results from two studies of heterogenerous nuclear ribonucleoprotein A2/B1 overexpressions. Clin Cancer Res 3: 2237-2246
19. Hirsch FR, Pfidiville SA, Miller YE et al. (2001) Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 43: 1385-1391
20. Venmans BJW, van Boxem TJM, Smit EF et al. (2000) Outcome of bronchial carcinoma in situ. Chest 117: 1572-1576
21. Mountain CF (1998) Revisions in the international system for staging lung cancer. Chest 111: 1710-1717
22. Luke W, Pearson F, Todd T et al. (1986) Prospective evaluation of mediastinoscopy for assesement of carcinoma of the lung. J Thoracic Cardiovasc Surg 91: 63-56
23. Deutsche Gesellschaft für Pneumologie und Deutsche Geseltschaft für Thorax-, Herz- und Gefäβchirurgie (1994) Empfehlungen zur Diagnostik, Stadieneinteilung und operativen Therapie des Bronchialkarzinoms. Pneumologie 48:262-269
24. Eberhardt W, Hepp R, Korff S, Stamatis G (2002) Current status of adjuvant and neoadjuvant chemotherapy in non-small cell lung cancer. Eur Respir Res 84: 196-207
25. Thomas M, Rübe C, Semik M et al.(1999) Impact of preoperativ bimodality induction including twice-daily radiation on tumour. Regression and survival in Stage III non-small cell lung cancer. J Clin Oncol 18: 118S-1193
26. PORT Metaanalysis Trialist (PMT) Group (1998) Postoperative radiotherapy in non small cell lung cancer: A systematic metaanalysis using individual data from nine randomized controlled trial. Lancet 352: 257-268
27. Saunders M, Dische S, Barrett A et al. (1999) Continuous hyperfractionated, accellerated radiotherapy (CHART) versus conventional radiotherapy in non small cell lung cancer: mature data from the randomised multicnetre trial. Radiother Oncol 52: 137-148
28. Sause W, Koleser P, Taylor S et al. (2000) Final Results of phase iii trial in regionally advanced unresectable nonsmall cell lung cancer. Chest 117: 3S8-364
29. Carney DN (2002) Lung cancer - time to move on from chemotherapy. N Engl J Med 346, 2: 126-128
30. Macha HN, Becker KO, Kemmer HP (1994) Pattern of failure and survival in endobronchial laserresection. A matched pair study. Chest 105: 1668-1672